Verition Fund Management
MRNA icon

Verition Fund Management’s Moderna MRNA Stock Holding History

Verition Fund Management’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-22,600
Closed -$1.51M – 3413
2024
Q3 		$1.51M Sell
22,600
-34,700
-61% -$3.19M 0.01% 1599
2024
Q2 		$6.8M Buy
57,300
+24,200
+73% +$3.06M 0.04% 542
2024
Q1 		$3.53M Buy
33,100
+28,100
+562% +$2.83M 0.02% 896
2023
Q4 		$497K Buy
+5,000
New +$421K ﹤0.01% 1521
2023
Q2 		– Sell
-8,400
Closed -$1.29M – 2416
2023
Q1 		$1.29M Hold
8,400
– – 0.02% 852
2022
Q4 		$1.51M Buy
8,400
+6,200
+282% +$1.01M 0.02% 740
2022
Q3 		$260K Hold
2,200
– – ﹤0.01% 2325
2022
Q2 		$315K Hold
2,200
– – 0.01% 1710
2022
Q1 		$379K Buy
+2,200
New +$370K ﹤0.01% 2057

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Verition Fund Management's MRNA Position: Q1 2026 in Review

Verition Fund Management sold out of Moderna (MRNA) in Q1 2026, closing a stake of 452,529 shares — an estimated $13.3M sold.

Verition Fund Management first reported a position in MRNA in Q2 2020 and held it in 20 quarters. The position peaked at $13.3M in Q4 2025. 723 funds tracked by Wall St. Rank hold MRNA as of Q1 2026.

  • Verition Fund Management reported no remaining Moderna position as of Q1 2026 after selling out during the quarter.
  • Verition Fund Management sold 452,529 Moderna shares in Q1 2026, an estimated $13.3M.
  • Verition Fund Management first reported a position in Moderna in Q2 2020 and held it in 20 quarters.
  • Verition Fund Management's Moderna position peaked at $13.3M in Q4 2025.
  • 723 funds tracked by Wall St. Rank held Moderna as of Q1 2026.

Based on Verition Fund Management's 13F filing for Q1 2026, filed 15 May 2026.